Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have ...

Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...

Scientists say they have identified a potential new gene target that could be edited to treat sickle cell disease, an ...

A 21-year-old man has become the first person in New York—and one of the first in the world—to be cured of sickle cell anemia ...

Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...

Scientists have found a potential new gene variant target to treat sickle cell disease, an inherited blood disorder that ...

Sebastien Beauzile, 21, has been cured of sickle cell anemia, according to his doctors at Cohen Children’s Medical Center.

“Now he’s producing normal adult hemoglobin in his parent cells. You see it in his blood as well,” Dr. Aygun said. “That’s why he’s not having any symptoms related to his sickle cell ...

A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR ...

Anemia remains a major public health concern in India, affecting women, children and pregnant mothers, leading to severe ...

Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its ...

Sickle cell anemia is the most common inherited blood disorder and affects roughly 100,000 people in the United States at a given time. It's caused by a mutation of the hemoglobin gene ...